Insights and Updates on Navigating the AML Landscape

Hagop M. Kantarjian, M.D., MD Anderson Cancer Center, Houston, TX

Recorded on March 28, 2024

Hagop M. Kantarjian, MD
Hagop M. Kantarjian, M.D.
Professor and Chairman, Department of Leukemia
Samsung Distinguished University Chair in Cancer Medicine
MD Anderson Cancer Center, University of Texas
Houston, TX
Join us for this episode as Dr. Hagop Kantarjian from MD Anderson Cancer Center discusses the latest advancements and progress in treating Acute Myeloid Leukemia (AML). From understanding genetic mutations to exploring emerging treatment options, Dr. Kantarjian shares valuable insights into the forefront of AML research and care. Learn more today!

Leave a Reply

Your email address will not be published. Required fields are marked *